Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Biogen Inc. Common Stock (BIIB) has a market cap of $25.99B with year-over-year revenue growth of +2.2%. Net margin stands at 13.1%. The stock trades at a P/E ratio of 20.1.
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, BIIB posted revenue growth of +2.2% and trades at a P/E of 20.1.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.